Tomas Tanskanen
Overview
Explore the profile of Tomas Tanskanen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1155
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sipila L, Tanskanen T, Heikkinen S, Seppa K, Aavikko M, Ravantti J, et al.
Acta Oncol
. 2024 Nov;
63:841-849.
PMID: 39492803
Background And Purpose: Many non-neoplastic diseases have been established to be tumorigenic, and cancers are sometimes misdiagnosed as non-neoplastic diseases. We conducted a comprehensive registry-based study of site-specific cancer diagnosis...
2.
Chen Z, Guo X, Tao R, Huyghe J, Law P, Fernandez-Rozadilla C, et al.
Nat Commun
. 2024 Apr;
15(1):3557.
PMID: 38670944
Genome-wide association studies (GWAS) have identified more than 200 common genetic variants independently associated with colorectal cancer (CRC) risk, but the causal variants and target genes are mostly unknown. We...
3.
Kalashnikov I, Tanskanen T, Viisanen L, Malila N, Jyrkkio S, Leppa S
Blood Cancer J
. 2023 May;
13(1):62.
PMID: 37185610
Marginal zone lymphoma (MZL) is an indolent B-cell malignancy with heterogeneous anatomical and clinical presentation. While MZLs are generally associated with long survival, some patients experience histological transformation to aggressive...
4.
Rantala J, Heikkinen S, Hirvonen E, Tanskanen T, Malila N, Pitkaniemi J
Int J Cancer
. 2023 Apr;
153(2):331-340.
PMID: 37074269
The risk of early-onset (EO) breast cancer is known to be increased in relatives of EO breast cancer patients, but less is known about the familial risk of other EO...
5.
Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, et al.
Nat Genet
. 2023 Feb;
55(3):519-520.
PMID: 36782065
No abstract available.
6.
Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, et al.
Nat Genet
. 2022 Dec;
55(1):89-99.
PMID: 36539618
Colorectal cancer (CRC) is a leading cause of mortality worldwide. We conducted a genome-wide association study meta-analysis of 100,204 CRC cases and 154,587 controls of European and east Asian ancestry,...
7.
Johansson A, Laronningen S, Skovlund C, Kristiansen M, Morch L, Friis S, et al.
Int J Cancer
. 2022 Apr;
151(3):381-395.
PMID: 35419824
The severity of the COVID-19 pandemic and subsequent mitigation strategies have varied across the Nordic countries. In a joint Nordic population-based effort, we compared patterns of new cancer cases and...
8.
Kalashnikov I, Tanskanen T, Pitkaniemi J, Malila N, Jyrkkio S, Leppa S
Blood Cancer J
. 2021 Dec;
11(12):203.
PMID: 34923571
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare B-cell malignancy associated with excellent survival. However, some patients experience histological transformation into aggressive large B-cell lymphoma. Population-based data on transformation...
9.
Miettinen J, Tanskanen T, Degerlund H, Nevala A, Malila N, Pitkaniemi J
J Biomed Inform
. 2021 Jun;
120:103850.
PMID: 34182148
Purpose: The Gleason score is an important grading factor of prostate cancer. Gleason scores can be extracted from pathology report texts using regular expressions, but previously developed programmes have targeted...
10.
Rajamaki K, Taira A, Katainen R, Valimaki N, Kuosmanen A, Plaketti R, et al.
Gastroenterology
. 2021 Apr;
161(2):592-607.
PMID: 33930428
Background & Aims: Inflammatory bowel disease (IBD) is a chronic, relapsing inflammatory disorder associated with an elevated risk of colorectal cancer (CRC). IBD-associated CRC (IBD-CRC) may represent a distinct pathway...